My lab recently got a phase II deficiency due to lack of adequate performance evaluations for pathologists. The cytotechnologists do not screen the non-gyn specimens. Looking at the CAP guidance, it seems to apply to performance evaluations of cytotechnologists. The inspector said since the pathologists are primary screeners, it applies. Anyone have any experience with this or in a similar situation? We want to contest the citation because we dont feel it applies.